Information  X 
Enter a valid email address

Ilika plc (IKA)

  Print      Mail a friend       Annual reports

Wednesday 29 May, 2019

Ilika plc

Custom Cell Capability

RNS Number : 3849A
Ilika plc
29 May 2019

Ilika plc

("Ilika" or the "Company")


Custom Cell Capability


Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that it has developed processing methods to enable rapid customisation of its Stereax thin film cells to match customers' requirements for form, fit and function.


The launch on 10th April 2019 of its Stereax® M50 mm-scale solid state batteries for MedTech was a defining step for Ilika's first product made using photolithography. This marked a move away from the use of contact masks, which were deployed to produce earlier Stereax products. Photolithography is a widely used microfabrication method in the semiconductor industry. It has the advantage over contact masks of being able to create smaller feature sizes, of less than a micron. The technique is therefore particularly suitable for forming Ilika's mm-scale range of Medtech batteries. In addition, the lead time for creating new wafer layouts is significantly reduced, by up to 85%, making it possible to respond to customers' requirements in an accelerated manner. Also, the operating costs of using a photolithographic process rather than contact masks are significantly less, in part due to the ability of photolithography to enable a tighter spacing of devices on wafers, increasing wafer yield.


Examples of MedTech devices which can benefit from Stereax battery technology are insulin pumps, cardiac devices, blood pressure monitors, neurostimulators, gastric stimulators, smart contact lenses and smart dental braces.


Relative to standard lithium ion batteries, Stereax solid state batteries are safer, have longer life spans of up to 10 years and lower leakage currents, making them suitable for low power wireless charging.


"The replacement of contact masks with a photolithographic method is an important step in being able to offer customised solutions to high value proprietary applications for Stereax products," added Ilika's CEO Graeme Purdy.



For more information contact:


Ilika plc

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Trystan Cullen, Cameron Duncan, William Hall

Walbrook PR Ltd

Tel: 020 7933 8780 / [email protected]

Paul McManus

Mob: 07980 541 893




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t